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CLINICOPATHOLOGICAL CASE CONFERENCE
A 59 year old man with progressive spinal cord
and peripheral nerve dysfunction culminating in
encephalopathy: Edinburgh advanced clinical
neurology course, 1999
R Al-Shahi, C P Warlow, G H Jansen, CJM Frijns, J van Gijn
Case presentation
A 59 year old, retired metal worker presented
with a 3 month history of diYculty walking. He
had initially developed left leg weakness,
followed 1 month later by numbness of both
legs, a burning sensation in his anal region and
penis, constipation, urinary frequency, reten-
tion, and incontinence. At that stage he
presented to another hospital with abdominal
pain, but all investigations for this were normal.
On examination there was some weakness of
his left leg, but no objective sensory loss in the
legs or perineum. The weakness progressed to
involve his right leg over the next 2 months
such that he needed a stick to walk.
For 6 years before presentation he had had
unremitting paraesthesiae of both shins, for
which no cause had been found. He had been
judged unfit to work 4 years previously due to
depression. Ankylosing spondylitis had been
diagnosed at the age of 30, followed by procti-
tis 10 years later for which he had been
successfully treated with sulphasalazine.
Cognitive, cranial nerve, cerebellar, and gen-
eral physical examination were unremarkable.
Upper arm and pectoralis muscles were
atrophied, but not weak. His gait was broad
based, stiV, and he dragged both feet. There
was bilateral MRC grade 4 weakness of knee
flexion and MRC grade 4+ weakness of the left
extensor hallucis longus muscle. Jaw jerk was
absent, but deep tendon reflexes in the arms
and legs were brisk with clonus at the right
ankle, an absent left ankle jerk, and up going
plantar responses. Pain and touch sensations
were diminished over both forearms, as they
were below both knees with additional impair-
ment of vibration sense.
Initial abnormal investigations were C reac-
tive protein 43.7 mg/l (reference range (RR)
0–8 mg/l), lactate dehydrogenase 638 µmol/l
(RR 300–620 µmol/l), serum angiotensin con-
verting enzyme (SACE) 28 U/l (RR 8–21 U/l)
rising to 36 U/l two months after presentation,
and protein electrophoresis showed two parap-
roteins, one band of IgG-ê and three bands of
IgM-ë. There were occasional leucocytes
(never more than 20 per high power field) and
some erythrocytes in the urine. Autoantibody
screen, erythrocyte sedimentation rate, HIV
and Lyme serology, tuberculin test, and the rest
of the serum biochemistry and urine examina-
tion were normal. Examination of the CSF on
three occasions demonstrated a maximal pro-
tein of 1.25 g/l, maximal white cell count of
13x106/l, IgG index of 0.50 (normal<0.60), no
growth from bacteriological cultures, and
unremarkable cytology and serology.
Magnetic resonance imaging of the lumbar
spine was initially normal, but on two subse-
quent examinations, within a month of presen-
tation, a small contrast enhancing lesion was
seen adjacent to a spinal root in the vicinity of
the medullary conus (fig 1). Brain MRI soon
after presentation showed small, scattered
lesions in the subcortical and periventricular
white matter (fig 2), with a larger lesion in the
right frontal lobe (fig 3); these appearances
were unchanged 3 months later. Initial EMG
showed denervation in the left gastrocnemius
and biceps femoris muscles. Nerve conduction
studies revealed normal velocities, action po-
tential amplitudes, F responses, and H reflexes
in motor and sensory nerves. The following
studies were consistently normal: MR imaging
of the cervical and thoracic cord, MR angio-
graphy of the whole cord, cerebral and spinal
catheter angiography, chest radiography, skel-
etal survey, CT of the thorax, ultrasound and
CT of the abdomen, sensory, motor (magnetic
stimulation) and visual evoked potentials, skin
biopsy, liver biopsy and bone marrow examina-
tion.
Over the next 3 months he developed
increasingly painful dysaesthesia and sensory
loss over his hands and feet. Due to this
deterioration he became increasingly depend-
ent on others and was unable to walk. Visual
acuity deteriorated to 6/7.5 on the right and
6/12 on the left, with photophobia, but no eye
pain; an ophthalmologist diagnosed anterior
uveitis and found a few small, peripheral retinal
haemorrhages. Livedo reticularis appeared
over his legs. At this stage he was treated with
75 mg per day oral prednisolone, increasing to
100 mg per day after 2 weeks, and gradually
tapered oV over subsequent weeks without any
clinical improvement.
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Four months after presentation he had a
generalised epileptic seizure which was compli-
cated by aspiration pneumonia requiring short
term mechanical ventilation. There was diVuse
slow wave activity on an EEG, with no abnor-
mal discharges. At that time his leg weakness
and muscle wasting progressed rapidly and a
follow up EMG showed denervation in all
muscles studied, aVecting the legs more than
the arms and distal more than proximal
muscles. Repeated nerve conduction studies
were abnormal in all nerves tested: action
potential amplitude was decreased in the motor
(CMAP 2 mV) and sensory (SNAP 3 µV)
fibres of the right median nerve, from which
distal sensory conduction velocity was 46 m/s
and motor conduction velocity was 48 m/s;
there were no responses from the motor fibres
of the right peroneal nerve, the sensory fibres of
either sural nerve, nor the right ulnar and radial
nerves. He became intermittently psychotic.
After another bout of aspiration pneumonia he
developed pulmonary embolism. He died after
another seizure, despite phenytoin treatment, 9
months after the beginning of his illness.
Sixteen days before his death an investigation
had been performed which suggested the diag-
nosis. A postmortem examination was per-
formed.
Discussion
CLINICAL FEATURES
Professor Charles Warlow
This 59 year old man’s final neurological illness
started with progressive problems aVecting his
legs and sphincters, immediately suggesting a
disorder of the spinal cord or cauda equina.
The first proper neurological examination was
normal above the neck, but there were definite
upper motor neuron signs in the legs—judged
by an expert on the Babinski sign in Utrecht.1
Sensory loss below the knees and an absent left
ankle jerk suggested an additional spinal root
problem. However, the sensory loss could have
been due to a cord lesion, so root or peripheral
nerve involvement was not definite. Rather
unexpectedly, there were upper limb signs
including brisk tendon jerks and “muscle atro-
phy” without weakness. But, on the whole, if
Figure 1 MR imaging of the lumbosacral spine (T1
weighted, sagittal section) with gadolinium contrast
showing a small, enhancing area in the vicinity of the
medullary conus (arrow).
Figure 2 Brain MRI (FLAIR, axial section) showing
scattered lesions in the subcortical and periventricular white
matter.
Figure 3 Brain MRI (FLAIR, axial section) showing a
lesion involving the grey and white matter of the right
frontal lobe (arrow).
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there is no weakness, then wasting should not
be used to localise a neurological lesion. So at
presentation this may not just have been a
lower spinal cord syndrome; there may have
been cervical cord pathology too. I shall come
back to the 5 year history of persisting pins and
needles in both shins.
In anyone with a deteriorating spinal cord
syndrome and upper limb signs, if not
symptoms, an MR scan of the whole cord is
needed. MR scans (without contrast, frustrat-
ingly) of the cervical, thoracic, and lumbar
spine were initially normal, apart from the
typical changes of ankylosing spondylitis. Two
months after initial presentation, however, a
repeat MR of the lumbar cord disclosed, with
gadolinium enhancement, a small enhancing
lesion seemingly attached to the meninges,
either at the conus, or on a spinal root (fig 1).
This could have been a tumour, granuloma, or
an infiltrative lesion. Inexplicably, a brain MR
had been performed before the lumbar spinal
MR, notwithstanding the lack of any problem
above the neck. Surprisingly, the scan was very
abnormal indeed (figs 2 and 3). The lesion in
the grey and white matter of the right frontal
lobe could have been an infarct or tumour, but
there was no mass eVect in favour of a
turnover; the scattered lesions were clearly
abnormal and did not look like multiple sclero-
sis, progressive multifocal leukoencephalopa-
thy, acute disseminated encephalomyelopathy
or small vessel disease, mostly because some of
the lesions were in cortical grey matter.
Given the more or less normal spinal
imaging, the CSF was examined, very sensibly
not just once but three times, disclosing a very
mild lymphocytic pleocytosis with normal
cytology and a slightly raised protein, but no
evidence of intrathecal immunoglobulin pro-
duction. Initial electrophysiological tests
showed denervation in the leg muscles inner-
vated just by the left L5 and S1 roots; only
much later did they demonstrate denervation
in the arm muscles as well, and impaired motor
and sensory conduction in the upper and lower
limbs suggesting not so much a generalised
neuropathy as mononeuritis multiplex.
After 3 months the patient was going from
bad to worse with definite motor and sensory
dysfunction in the upper as well as the lower
limbs. Further to the raised lactate dehydroge-
nase and C reactive protein and paraproteinae-
mia, a systemic disorder was suggested by
livedo reticularis, uveitis, and retinal haemor-
rhages. But skin, liver, and bone marrow biop-
sies were all frustratingly normal. A generalised
epileptic fit heralded a further decline, despite
corticosteroid treatment, and focused minds
on the brain because an EEG was done the
next day and showed diVuse abnormalities
consistent with a global encephalopathy. Fur-
ther imaging of the brain was unhelpful but
“another procedure” was performed which
suggested the diagnosis 16 days before his
death.
Asking the first question in neurological
diagnosis, “where is the lesion?” it is clear that
this patient did not have one focal lesion, but a
multifocal or diVuse pathological process,
aVecting his brain, spinal cord, nerve roots, and
peripheral nerves too. Answering the second
question, “what is the lesion?” is much more
diYcult because the multitude of abnormalities
suggests a range of possibilities. His age puts
neoplasia high on the list, the rate of progres-
sion again suggests neoplasia or chronic
inflammation, and there were very important
hints at a systemic illness (paraproteinaemia,
raised SACE, acute phase response, livedo
reticularis, haematuria, retinal haemorrhages,
and uveitis), let alone the ankylosing spondyli-
tis and inflammatory bowel disease.
Taking the systemic clues one at a time, the
only neurological complication attributable to
ankylosing spondylitis is a cauda equina
syndrome, but the patient had far more than
that.2 There are numerous neurological com-
plications of and associations with inflamma-
tory bowel disease (suggested by the patient’s
proctitis) but they are all very rare, especially
with quiescent disease.3 I do not think that the
sulphasalazine was responsible, although it can
very rarely cause neurological disorders (dis-
similar to this patient’s syndrome) that are said
to occur shortly after starting the drug.4
A mildly raised C reactive protein is very
non-specific, but it does suggest some sort of
underlying systemic inflammation, although
the spondylitis or proctitis could have been
responsible for this. A malignancy or chronic
infection cannot be excluded by a normal
erythrocyte sedimentation rate, nor can they be
implicated by a mildly raised lactate dehydro-
genase. I think that the haematuria was
probably insignificant in the absence of urinary
casts and renal dysfunction. A raised SACE is
neither a sensitive nor a specific test for
sarcoid.5 Even though the patient was some
sort of metal worker, I do not think that this is
relevant. Too much reliance should not be
placed on the negative tuberculin test as
sarcoid, lymphoma, and any serious illness,
including tuberculosis itself and monoclonal
gammopathy, can all suppress cell mediated
immunity. The biclonal paraproteinaemia
could be attributed to a very rare biclonal
myeloma, but the bone marrow was normal
(we are not told whether this was by trephine,
which would have been more likely than just an
aspirate to pick up any abnormality) and there
was no bone pain, nor lesions on skeletal
survey, anaemia, renal failure, raised erythro-
cyte sedimentation rate, hypercalcaemia, or
Bence-Jones proteinuria. Many of the other
causes of paraproteinaemia can be rejected, but
Box 1: Causes of paraproteinaemia
Multiple myeloma/solitary plasmacytoma
Waldenström’s macroglobulinaemia
Monoclonal gammopathy of undetermined
significance (MGUS)
POEMS syndrome (polyneuropathy,
organomegaly, endocrinopathy, monoclonal
gammopathy, skin lesions)
Primary amyloidosis
B cell lymphomas
Chronic lymphocytic leukaemia
Mixed essential cryoglobulinaemia
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I will come back to amyloid, lymphoma, and
mixed essential cryoglobulinaemia (box 1).
Livedo reticularis has a wide diVerential
diagnosis (box 2), and in the context of this
case vasculitides, intravascular obstruction,
and lymphoma need to be considered. I guess it
was the livedo that led to the skin biopsy, but
that was reported as normal. The patient’s two
ophthalmological problems were far from spe-
cific. We are told that the uveitis was anterior,
but there was no pain, watering, or reddening,
so maybe this was really posterior uveitis rather
than iridocyclitis. Regardless, the uveitis may
be attributable to the spondylitis or proctitis
but among the many other causes of uveitis I
will return to sarcoid (suggested by raised
SACE), a chronic infection perhaps, malig-
nancy, and vasculitis. Retinal haemorrhages
also occur in many of the things we may be
interested in, including vasculitis. So the eyes
are not a lot of help except to confirm that we
must be dealing with a systemic and not just a
neurological disease.
I do not think that this illness was due to
some sort of mycobacterial or fungal chronic
infection as the clinical picture and investiga-
tions were not consistent with such a diagnosis;
furthermore, the paraproteinaemia and long-
standing paraesthesiae, if relevant, would
remain unexplained. Cancer has to be consid-
ered because the systemic disease was progres-
sive and killed the patient in 9 months. I do not
think the cerebral lesions were metastases
because they were the wrong shape, there was
no mass eVect, and they did not grow. Nor does
malignant meningitis fit, although the enhanc-
ing cord lesion could have been a meningeal
metastasis. There were none of the clinical fea-
tures of chronic meningitis, the CSF was not
particularly abnormal, and the glucose was
normal. The CSF cytology was normal al-
though it can remain so in malignant meningi-
tis even after several lumbar punctures, and
also he survived too long without treatment for
malignant meningitis. Nor are we dealing with
a paraneoplastic syndrome because there was
no evidence of a primary tumour, the cerebral
MR changes were so pronounced, the spinal
lesion on MR would remain unexplained, and
any neuropathy is usually distal, symmetric,
and sensory. And, of course, the livedo
reticularis and paraproteinaemia would have to
be explained. Primary amyloidosis is worth
considering because of its association with a
paraproteinaemia, but its neurological compli-
cations are dissimilar to this case (diVuse
peripheral neuropathy with a strong autonomic
component is the most common manifestation,
while entrapment neuropathies, myopathy and
cranial neuropathies are very rare) and none of
its systemic complications were present.
DIFFERENTIAL DIAGNOSIS
There are three possibilities that must surely
include the diagnosis. Lymphoma is a candi-
date in the face of a widespread and obscure
neurological disorder with uveitis and a parap-
rotein (which can appear with, or long before,
lymphomas of the B cell type). I do not think,
however, that either a systemic or primary CNS
lymphoma is the cause. There are absolutely no
cerebral or spinal masses apart from the very
small spinal lesion, and the meningitis is not at
all likely to be malignant with a 9 month
survival. Moreover, primary CNS lymphoma
would not explain the mononeuritis multiplex
and livedo reticularis.6
The second possibility is sarcoidosis in view
of the cerebral infarcts, or perhaps granuloma-
tous changes on the brain MR, spinal cord
involvement, root and peripheral nerve signs,
uveitis, and raised SACE (box 3). The CSF was
compatible. Knowing the CSF ACE, which is
neither a specific nor sensitive test, would not
have helped.5 But, many features were not con-
sistent with sarcoid, including the patient’s age,
normal liver and skin biopsies, lack of response
to steroids, and the relentlessly progressive
clinical course. Nor are paraproteins or livedo
reticularis found with sarcoid.
The third possibility is one of the myriad of
vasculitides, suggested by such a diVuse disease
of the nervous system, what look like infarcts
on the brain MR, livedo reticularis, and the
exclusion of more or less everything else in the
diVerential. I do not think that it was a systemic
necrotising vasculitis such as microscopic poly-
angiitis or polyarteritis nodosa because the rel-
evant antibodies were negative, there was no
renal impairment, and the erythrocyte sedi-
mentation rate was normal.7 Nor do I think it
was isolated angiitis of the CNS, because this
Box 2: Causes of acquired livedo reticu-
laris
Vessel wall disease:
Vasculitis, atherosclerosis
Intravascular obstruction:
Hypercoagulability, paraproteinaemia, cryo-
globulinaemia, cholesterol embolisation syn-
drome, disseminated intravascular coagula-
tion, decompression sickness
Infections:
Tuberculosis, meningococcus, endocarditis,
syphilis, typhus fever
Drugs:
Amantadine, quinine, catecholamines
Metabolic/endocrine:
Cushing’s disease, hypothyroidism, pellagra
Miscellaneous:
Cardiac failure, lymphoma, oxalosis, acute
pancreatitis
Box 3: Neurological complications of
sarcoidosis
Chronic meningitis±cranial neuropathies
Brain and meningeal granulomata
Infiltration of the optic nerve/orbit/chiasm
Spinal cord/root granulomata
Sarcoid angiitis of the brain/spinal cord
Mononeuropathy, mononeuritis multiplex,
polyneuropathy
Muscle granulomata
Opportunistic infections
CSF may have mildly raised lymphocytes,
protein and immunoglobulin synthesis, and
a slightly low glucose
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does not aVect peripheral nerves, and there
should not be so many systemic features such
as the livedo reticularis, uveitis, retinal haemor-
rhages and raised C reactive protein.8 Clearly
the vasculitides associated with Behçet’s dis-
ease, rheumatoid arthritis, Sjögren’s syndrome,
relapsing polychondritis, systemic sclerosis,
and malignant atrophic papulosis do not fit
because there were none of their specific
features. The clinical picture was wrong for
giant cell arteritis and Takayasu’s disease. The
cholesterol embolisation syndrome can mas-
querade as systemic vasculitis with livedo
reticularis, but the electrolyte sedimentation
rate was not raised and there was no suggestion
of widespread and severe atheroma.9 I do not
think that this man had systemic lupus
erythematosus because he was the wrong age
and sex, the only other organs aVected were the
skin and eyes, antinuclear antibodies were
negative, and the C reactive protein should not
have been raised. I wonder why the results of
the antiphospholipid antibody level and the
lupus anticoagulant assay were not given, or
any indication that transoesophageal echo-
cardiography was done looking for mitral valve
vegetations. Was this the late breaking thought
and so the diagnostic test that suggested the
diagnosis? Although the livedo reticularis is
suggestive of the antiphospholipid antibody
syndrome, as are the ischaemic looking lesions
on brain MR, spinal cord involvement is almost
unheard of and the peripheral nerves are never
involved.10 Turning to the paraproteins, the
only vasculitis I know to be associated with a
serum paraprotein is mixed essential cryoglob-
ulinaemia. This disease is a systemic vasculitis
aVecting arteries and veins, in the presence of a
circulating cryoglobulin. Many of the systemic
features of mixed essential cryoglobulinaemia
were not present, and its principal neurological
complications are an axonal peripheral neu-
ropathy or mononeuritis multiplex.11 I have
found only two case reports of a subacute
encephalopathy caused by occlusion of small
cerebral vessels, thought to be due to the
precipitation of cryoglobulins,12 13 but in the
presence of obvious systemic illness, unlike our
case. Any spinal cord involvement is, I think,
unheard of, the disease tends to be more
chronic than what we are dealing with here
and, finally, the paraprotein is normally a single
monoclonal IgG with a polyclonal response,
not biclonal.
The only other possible diagnosis in my
mind is intravascular lymphoma. It is exceed-
ingly rare and so perfect for a clinicopathologi-
cal conference.14–16 The neurological features
(box 4) are probably all due to vascular
plugging by malignant lymphoma cells.17 18 The
features that would seem to fit with this
diagnosis are widespread neurological involve-
ment in the presence of a non-specific CSF,
rapid progression to death, normal bone
marrow and liver biopsies, uveitis, and retinal
haemorrhages. Livedo reticularis, paraprotein-
aemia, and raised SACE have all been de-
scribed and the normal erythrocyte sedimenta-
tion rate and raised C reactive protein do not
exclude the diagnosis. The lactate dehydroge-
nase and erythrocyte sedimentation rate are
usually higher, but they do not have to be. The
patient’s early abdominal pain may have been
attributable to mesenteric ischaemia and his
longstanding paraesthesiae caused by parapro-
teinaemia (which might have been regarded as
a benign gammopathy in the early stages). The
normal skin biopsy would seem to be inconsist-
ent, but this may have missed the patchy
vascular lesions. The small, enhancing lesion
near the cauda equina could have been an
extravascular deposit. I am troubled by the lack
of progression of the MR changes and if the
frontal lesion (fig 3) was an infarct due to
intravascular lymphoma, it is odd that no atro-
phy developed around it with enlargement of
the frontal horn.
To achieve a diagnosis during life, short of
sitting down quietly, taking the history again
from scratch, re-examining the patient, and
looking at all the investigations yet again, I
would have done a brain biopsy. I think that
such a biopsy would have shown intravascular
lymphoma.
Questions
Professor Jan van Gijn
“Would you put a number to your degree of
certainty about intravascular lymphoma as the
primary diagnosis?”
Professor Charles Warlow
“Yes, 100%.”
Member of the audience
“Why would you not have done a sural nerve
biopsy?”
Professor Charles Warlow
“I would have been thinking of lymphoma or
vasculitis so, in the presence of three normal
biopsies elsewhere, I would have gone straight
for the right frontal lesion, to get a sample of
meninges and cortex, in other words something
that was so obviously aVected.”
Dr Geraint Fuller
“Why not biopsy the lesion near the conus?”
Professor Charles Warlow
“I think that might have been technically diY-
cult. What does a neurosurgeon think?”
Box 4: Neurological features of intra-
vascular lymphoma18
Multifocal cerebral infarcts causing stroke-
like episodes and a chronic or subacute
encephalopathy (rarely transient ischaemic
attacks)
Spinal cord syndrome with pain
Peripheral/cranial neuropathy and radicu-
lopathy
Raised CSF protein with lymphocytic pleo-
cytosis
Non-specific beading and dilatations on
cerebral arteries seen on angiography
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Mr John Garfield
“It might be possible, but I, like you, would
biopsy the pathology in the brain.”
Professor Jan van Gijn
“Where would a muscle expert have directed his
investigations, in view of the electrophysiology?”
Dr David Hilton-Jones
“You want me to say biopsy muscle, of course!
Biopsying asymptomatic muscle is not highly
productive. If the sural nerve neurophysiology
was abnormal, I think that would not be an
unreasonable place to look.”
Member of the audience
“I wonder if the patient’s illness could have
been related to spinal irradiation in the past as
treatment for ankylosing spondylitis?”
Professor Charles Warlow
“I don’t think that would be consistent with
such a rampant 9 month history, or the brain
involvement.”
Professor Michael Harrison
“Was it true that there was no enhancement on
the cranial MR?”
Professor Charles Warlow
“Contrast was not administered with his
cranial MR—a major omission!”
Professor Jan van Gijn
“Ian, what are your thoughts?”
Professor Ian McDonald
“John Garfield and I were just saying to each
other that we have not even heard of a number
of these conditions! As one of Charles’
teachers, I got as far as lymphoma, but I did not
know about intravascular lymphoma, although
I am persuaded by this.”
Professor Jan van Gijn
“Michael Donaghy, what did you think?”
Dr Michael Donaghy
“Well it is now clear to me that it must have
been one of: sarcoidosis, intravascular
lymphoma or vasculitis! I think the livedo
reticularis puts one oV sarcoid, but I am
persuaded by Charles’ diagnosis.”
Dr Jan van Gijn
“Could we have the last word from Newcas-
tle?”
Dr David Bates
“I must be slightly disingenuous because I
thought this was a B cell lymphoma, but I am
attracted by the concept of this being intravas-
cular lymphoma, although I am worried
slightly by the lack of change in the MR scan
over the 3 months.”
Pathology
Dr Gerard Jansen
At postmortem the heart, liver, and kidneys
were normal. The spleen was enlarged and sof-
tened, and several petechial haemorrhages
were present in the mucosa of the stomach.
The lungs were congested with four small
hemorrhagic infarcts due to pulmonary em-
boli.
External examination of the brain, which
weighed 1550 g, was normal. Internal exam-
ination showed small patches of discolouration
and softening of the right frontal cortex and the
left precentral gyrus. The brain stem, cerebel-
lum, and spinal cord were macroscopically
normal. On microscopy of the frontal cortical
ribbon there was widespread gliosis and a small
infarct. Similar appearances were scattered
throughout the brain. There was demyelination
of the white matter and occasional macro-
phages, which led me to examine the blood
vessels further. Whole vessels in the white mat-
ter were completely clogged with mitotic,
rounded cells (fig 4), which were also found in
other organs. These neoplastic cells were
CD-20 and CD-79a positive, and expressed ê
light chains (fig 5), but not heavy chain immu-
noglobulins. There were no CD-3 or other T
Figure 4 Intracortical vein showing atypical lymphoid cells with mitosis (haematoxylin
and eosin, magnification×100).
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cell marker positive tumour cells. These atypi-
cal lymphoid cells were also found in renal
glomeruli, the pulmonary and coronary vascu-
lature; in fact the only two tissues which
seemed unaVected were the lymph nodes and
bone marrow. These are the appearances of an
intravascular B cell lymphoma.
The diagnostic tests that were performed
shortly before the patient’s death were nerve
and muscle biopsies. Although there was no
evidence of intravascular lymphoma from the
sural nerve biopsy, the myelinated nerve fibres
were considerably reduced in number. The
muscle biopsy confirmed atrophy, but this was
not necessarily neurogenic in the absence of
grouping of the same types of fibre. Within the
vessels, however, there were the same CD-20
positive large B cells found elsewhere in the
necropsy. In retrospect, detailed examination
of the skin biopsy performed 2 months before
death also showed occasional intravascular
lymphomatous cells, predominantly in the
venules.
Questions
Professor Charles Warlow
“What was going on in the spinal roots?”
Dr Gerard Jansen
“Exactly the same process. At the lower sacral
level in the spinal canal there was an arachnoi-
dal artery with intraluminal tumour cells and
surrounding T lymphocytes close to the dorsal
root.”
Professor Charles Warlow
“Were the spinal roots enlarged enough to pro-
duce the mass lesion on MR?”
Dr Gerard Jansen
“No gross enlargement was present. The
vessels were more aVected there, but that is all.
Presumably the small lesion on MR imaging
was an artefact.”
Dr David Bates
“Why do the lymphoma cells adhere to the
endothelium? Do they induce adhesion mol-
ecules?”
Dr Gerard Jansen
“It is thought that a lack of the CD-18
glycoprotein, which mediates cell to cell adhe-
sion of lymphocytes, may be responsible for the
predominantly intravascular location of the
lymphoma.19”
Dr Alistair Lammie
“Are these vessels actually occluded leading to
cerebral infarction, or is it perhaps a sludging
phenomenon?”
Dr Gerard Jansen
“In quite a few instances these blood vessels
must become occluded because recanalisation
is found. However, partial ischaemia due to
sludging cannot be entirely ruled out.”
Dr Geraint Fuller
“If the lymphoma cells were there on the skin
biopsy, were they also there in the liver or bone
marrow biopsies?”
Dr Gerard Jansen
“There were no abnormal large lymphocytes,
but they may have been masked by the
abundance of lymphocytes in the liver biopsy
due to drug treatment and several blasts in the
bone marrow.”
Professor Jan van Gijn
“The muscle biopsy finally suggested the diag-
nosis before death, but in retrospect it could
have been made on the earlier skin biopsy.”
Professor Charles Warlow’s diagnosis
Intravascular lymphoma
Pathological diagnosis
Intravascular lymphoma
Figure 5 Arachnoid vein showing ê light chain positive tumour cells within the lumen,
and smaller extravascular non-stained T lymphocytes (anti-ê Dako, original
magnification×100).
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Comment
There have been fewer than 200 cases of intra-
vascular lymphoma reported after its first
description by Pfelger and Tappeiner in 1959.20
The disease was originally called neoplastic or
malignant angioendotheliomatosis and angio-
tropic large cell lymphoma, but it has been
renamed in view of the lymphoid, rather than
endothelial, cellular diVerentiation.21 22 Intra-
vascular lymphoma is usually high grade and of
the B cell phenotype. It has been distinguished
from primary CNS lymphoma and Hodgkin’s
lymphoma by the absence of p53 and bcl-2
proteins.23 A generalised, monoclonal intravas-
cular expansion of malignant lymphocytic cells
causes widespread small vessel occlusion, with
occasional extravasation.
Like other non-Hodgkin’s lymphomas, intra-
vascular lymphoma has a predilection for mid-
dle aged and elderly people, and tends to aVect
men more often than women. In two thirds of
patients the presentation is with neurological
disease,17 18 but it may also include intermittent
fever and skin rashes. A review of the
literature18 has identified four main presenting
neurological syndromes reflecting the process
of vascular occlusion: chronic or subacute
encephalopathy, multifocal cerebral infarction,
myelopathy, and peripheral or cranial neuropa-
thies. The usual CSF findings of a mild
increase in protein and lymphocytic pleocytosis
are non-specific, as are increase in plasma lac-
tate dehydrogenase and erythrocyte sedimen-
tation rate. Patients tend to have multifocal
cerebral infarction with an aYnity for the deep
white matter and occasional meningeal en-
hancement on MR imaging.24
Intravascular lymphoma is rarely diagnosed
during life25 as malignant cells are seldom
found in the CSF, blood, or bone marrow.
Without histological confirmation, its diVeren-
tiation from other disorders such as vasculitis26
and isolated angiitis of the CNS27 can be diY-
cult. Tissue biopsy may be a worthwhile aid to
antemortem diagnosis, because survival of over
2 years has been reported after chemo-
therapy,28 29 although radiotherapy, steroids,
and plasmapharesis do not appear beneficial.30
The prognosis is otherwise limited to a median
of 5 months.25
We are grateful to Ms Rosemary Anderson for her assistance
with transcription of the manuscript. RAS is supported by a
Medical Research Council Clinical Training Fellowship.
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